Publications by authors named "Ramtin Omid-Shafaat"

Article Synopsis
  • Type 2 diabetes mellitus (T2DM) can lead to severe complications, including diabetic nephropathy (DN), which is linked to liver-derived factors known as hepatokines, particularly Angiopoietin-Like Protein 3 (ANGPTL3).
  • In a study involving 60 healthy individuals, 60 T2DM patients, and 61 DN patients, researchers measured serum levels of ANGPTL3, IL-6, and TNF-α, finding significantly higher ANGPTL3 levels in both T2DM and DN patients compared to controls, with DN patients showing the highest levels.
  • The results suggest that ANGPTL3 is associated with renal dysfunction and lipid metabolism, potentially playing a
View Article and Find Full Text PDF

Purpose: Fluoropyrimidines, the major chemotherapeutic agents in various malignancies treatment, are metabolized by dihydropyrimidine dehydrogenase (DPD). DPD deficiency can lead to severe and sometimes fatal toxicity. In the present study, we developed a simple protocol to detect the DPYD*2A variant.

View Article and Find Full Text PDF

Background: Recently, measurement of serum circular RNAs (circRNAs) as a non-invasive tumor marker has been considered more. We designed the present study to investigate the diagnostic efficiency of serum Circ-ELP3 and Circ-FAF1, separately and simultaneously, for diagnosis of patients with breast cancer.

Methods: Seventy-eight female patients diagnosed as primary breast cancer participated in this study.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ramtin Omid-Shafaat"

  • - Ramtin Omid-Shafaat's recent research primarily focuses on the impact of biomolecular factors in health conditions, particularly relating to diabetic nephropathy and various cancers, exploring how these factors can influence diagnosis and treatment pathways.
  • - In his 2023 study, he highlighted elevated serum levels of angiopoietin-like protein 3 in diabetic nephropathy patients, suggesting a significant association with renal function and lipid profiles, which could have implications for managing complications in type 2 diabetes.
  • - Additionally, Omid-Shafaat contributed to the field of pharmacogenetics by developing a cost-effective RT-PCR protocol for detecting the DPYD*2A polymorphism in the Kurdish population, aiming to enhance patient safety in treatment with fluoropyrimidine-based chemotherapies.